Terms: = Lung cancer AND FEV, Pet-1, 54738, ENSG00000163497, PET-1, HSRNAFEV AND Prognosis
18 results:
1. Protective effect of height on long-term survival of resectable lung cancer: a new feature of the lung cancer paradox.
Daffré E; Porcher R; Iannelli A; Prieto M; Brouchet L; Falcoz PE; Le Pimpec Barthes F; Pages PB; Thomas PA; Dahan M; Alifano M
Thorax; 2024 Mar; 79(4):316-324. PubMed ID: 38359923
[TBL] [Abstract] [Full Text] [Related]
2. Value of preoperative evaluation of fev
Li W; Zhao J; Gong C; Zhou R; Yan D; Ruan H; Liu F
BMC Pulm Med; 2024 Jan; 24(1):39. PubMed ID: 38233903
[TBL] [Abstract] [Full Text] [Related]
3. Factors associated with quality of life in patients receiving lung transplantation: a cross-sectional study.
Takahashi R; Takahashi T; Okada Y; Kohzuki M; Ebihara S
BMC Pulm Med; 2023 Jun; 23(1):225. PubMed ID: 37353819
[TBL] [Abstract] [Full Text] [Related]
4. NSCLC patients with a changing T grade after operation may represent a special subset of tumor staging.
Feng KP; Fu K; Xu C; Ding C; Zhu XY; Pan B; Jia XY; Zhao J; Li C
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9991-9998. PubMed ID: 37258719
[TBL] [Abstract] [Full Text] [Related]
5. Determinants of Progression and Mortality in Lymphangioleiomyomatosis.
Xu W; Yang C; Cheng C; Wang Y; Hu D; Huang J; He Y; Wang J; Chen K; Yang L; Zhou W; Zhang T; Liu S; Dai J; Meng S; Li X; Yang Y; Wang ST; Feng R; Zhang W; Zhang H; Wang L; Tian X; Xu KF
Chest; 2023 Jul; 164(1):137-148. PubMed ID: 36801466
[TBL] [Abstract] [Full Text] [Related]
6. Long-term clinical course and outcomes in patients with lymphangioleiomyomatosis.
Yoon HY; Kim HJ; Song JW
Respir Res; 2022 Jun; 23(1):158. PubMed ID: 35717210
[TBL] [Abstract] [Full Text] [Related]
7. Impact of coexistent preserved ratio impaired spirometry on the survival of patients with lung cancer: Analysis of data from the Korean Association for lung cancer Registry.
Heo IR; Kim HC; Lee SJ; Yoo JW; Ju S; Jeong YY; Lee JD; Cho YJ; Jeong JH; Heo M; Jung SW; Kim TH
Thorac Cancer; 2021 Sep; 12(18):2478-2486. PubMed ID: 34337879
[TBL] [Abstract] [Full Text] [Related]
8. Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer.
Yi YS; Ban WH; Sohng KY
BMC Cancer; 2018 Oct; 18(1):1053. PubMed ID: 30373585
[TBL] [Abstract] [Full Text] [Related]
9. Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell lung cancer.
Takamori S; Toyokawa G; Okamoto T; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takada K; Katsura M; Hirai F; Shoji F; Tagawa T; Oda Y; Honda H; Maehara Y
Ann Surg Oncol; 2018 May; 25(5):1229-1236. PubMed ID: 29327178
[TBL] [Abstract] [Full Text] [Related]
10. The Evaluation of Interstitial Abnormalities in Group B of the 2011 Global Initiative for Chronic Obstructive lung Disease (GOLD) Classification of Chronic Obstructive Pulmonary Disease (COPD).
Ohgiya M; Matsui H; Tamura A; Kato T; Akagawa S; Ohta K
Intern Med; 2017 Oct; 56(20):2711-2717. PubMed ID: 28924113
[TBL] [Abstract] [Full Text] [Related]
11. prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.
Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
Lancet Respir Med; 2017 May; 5(5):426-434. PubMed ID: 28389225
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical and paraclinical prognostic factors in non-small cell lung cancer surgery].
Riquet M; Rivera C; Pricopi C; Badia A; Arame A; Dujon A; Foucault C; Le Pimpec-Barthes F; Fabre E
Rev Pneumol Clin; 2015 Oct; 71(5):264-74. PubMed ID: 26315208
[TBL] [Abstract] [Full Text] [Related]
13. Development of a patient-centered aggregate score to predict survival after lung resection for non-small cell lung cancer.
Brunelli A; Salati M; Refai M; Xiumé F; Berardi R; Mazzanti P; Pompili C
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):385-90.e1-2. PubMed ID: 23651911
[TBL] [Abstract] [Full Text] [Related]
14. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population.
Lange P; Marott JL; Vestbo J; Olsen KR; Ingebrigtsen TS; Dahl M; Nordestgaard BG
Am J Respir Crit Care Med; 2012 Nov; 186(10):975-81. PubMed ID: 22997207
[TBL] [Abstract] [Full Text] [Related]
15. Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation.
Bergeron A; Belle A; Chevret S; Ribaud P; Devergie A; Esperou H; Ades L; Gluckman E; Socié G; Tazi A
Bone Marrow Transplant; 2007 May; 39(9):547-53. PubMed ID: 17351647
[TBL] [Abstract] [Full Text] [Related]
16. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer.
Gore JM; Brophy CJ; Greenstone MA
Thorax; 2000 Dec; 55(12):1000-6. PubMed ID: 11083884
[TBL] [Abstract] [Full Text] [Related]
17. Bronchoplastic procedures for bronchial carcinoma.
Røder OC; Christensen JB; Andersen C; Andersen K; Oxhøj H
Scand J Thorac Cardiovasc Surg; 1987; 21(2):109-11. PubMed ID: 3616536
[TBL] [Abstract] [Full Text] [Related]
18. Plasma angiotensin-converting enzyme activity in patients with bronchial carcinoma.
Roulston JE; Galloway PJ; Douglas G
Br J Dis Chest; 1986 Jul; 80(3):229-34. PubMed ID: 3024690
[TBL] [Abstract] [Full Text] [Related]
